Quiz: Cancer Immunology MSCI500 (B01), BIOM500 (B01) 2024 Questions and Answers Graded A+.

Quiz: Cancer Immunology MSCI500 (B01), BIOM500 (B01) 2024 Questions and Answers Graded A+. Score for this quiz: 37out of 40 Submitted Sep 28 at 11:34am This attempt took 40 minutes. 2 / 2 pts Question 1 Biomarkers of effect measure early biological alterations that occur in the time frame between exposure and cancer development and are also known as biomarkers of intermediate endpoints or intermediate biomarkers. True False Question 2 2 / 2 pts Quiz: Cancer Immunology: MSCI500 (B01), BIOM500 (B01) Biomarkers of exposure can provide the most direct evidence of human exposure to a carcinogen as well as internal dose and biologically effective dose, a rm exposure-cancer associations established from traditional epidemiological approaches, and provide biological plausibility for the observed exposure-cancer association. True False Question 3 4 / 4 pts Which of these is an example of a biomarker of internal dose? Check all that apply; Hormones Nutrients in body uids Circulating antibodies Cotinine 2 / 2 pts Question 4 The genes for the human type I IFNs lack introns and those those encoding 14 subspecies of IFN-α, are clustered on chromosome 9. Quiz: Cancer Immunology: MSCI500 (B01), BIOM500 (B01) True False .